Showing 5101-5110 of 5644 results for "".
- Positive Phase 3 Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum Disorder Published in NEJMhttps://modernod.com/news/positive-phase-3-results-for-genentechs-satralizumab-in-neuromyelitis-optica-spectrum-disorder-published-in-nejm/2477130/Genentech announced that data from SAkuraSky, a pivotal phase 3 study of the investigational medicine satralizumab for the treatment of neuromyelitis optica spectrum disorder (NMOSD), were published in the November 27, 2019 online issue of the New England Journal of Medicine (NEJM).
- AI Screening for Diabetic Retinopathy Moves to Retail Clinicshttps://modernod.com/news/ai-screening-for-diabetic-retinopathy-moves-to-retail-clinics/2477127/Retail health clinics have been part of the trend in making healthcare more convenient, and now another option is being offered—testing for diabetic retinopathy—according to a Medscape report. However, an ophthalmologist won’
- Mark McGrath to Headline Celebration at Optometry’s Meeting 2020https://modernod.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/The American Optometric Association has announced that it is celebrating the decade of the 90s at its annual Optometry’s Meeting, June 24-28, in National Harbor, Maryland/Washington, D.C. “Mark McGrath’s ’90s Experience” will headline the closing Celebration o
- Vance Thompson Vision Acquires Nebraska Laser Eye Institutehttps://modernod.com/news/vance-thompson-vision-acquires-nebraska-laser-eye-institute/2477125/Vance Thompson Vision, a provider of ophthalmology and refractive surgery in South Dakota, North Dakota, Montana, Minnesota, Nebraska
- Teva, Drugmakers in Talks With U.S. to End Generics Probeshttps://modernod.com/news/teva-drugmakers-in-talks-with-u-s-to-end-generics-probes/2477123/Teva Pharmaceutical Industries and other generic drugmakers have held talks with the U.S. Justice Department in the past 6 months about resolving a long-running criminal antitrust probe of alleged price-fixing by the companies, according to people familiar with the matter, as
- CooperVision Earns Global Impact Award for Rebate Donation Program Resulting in $800,000 Raised for Optometry Giving Sighthttps://modernod.com/news/coopervision-earns-global-impact-award-for-rebate-donation-program-resulting-in-800000-raised-for-optometry-giving-sight/2477119/CooperVision offers a contact lens rebate donation program that enables consumers to designate all or part of their rebates to be given to Optometry Giving Sight (OGS). Seven years after the launch of that program, CooperVision has been recognized by 360insights, the company’s rebate and incentiv
- Clearwave Announces Interface with Modernizing Medicinehttps://modernod.com/news/clearwave-announces-interface-with-modernizing-medicine/2477113/Clearwave, a provider of patient check-in solutions via mobile, kiosk and desktop, announced a new interface with award-winning health IT company, Modernizing Medicine. This announcement comes as Modernizing Medicine’s 2019 user conference, MOMENTUM, kicks off in Orlando, Florida. The Clea
- ProtoKinetix AAGP Dry Eye Therapy Program Launchedhttps://modernod.com/news/protokinetix-aagp-dry-eye-therapy-program-launched/2477115/ProtoKinetix announces the initiation of a program testing AAGP to develop a potential therapy to treat dry eye disease (DED). AAGP has demonstrated anti-inflammatory and cytoprotective properties, and also exhibits pharmaceutical properties beneficial for topical formulations, according to a com
- Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernod.com/news/baring-private-equity-asia-agrees-to-acquire-lumenis/2477103/Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology from XIO. The transaction values Lumenis at an ent
- Nidek Launches the YC-200 and YC-200 S Plus in the United Stateshttps://modernod.com/news/nidek-launches-the-yc-200-and-yc-200-s-plus-in-the-united-states/2477101/Nidek has announced that the FDA has issued 510(k) clearance for the YC-200 Ophthalmic YAG Laser System. The YC-200 includes the S plus model for Selective Laser Trabeculoplasty (SLT). With FDA clearance, the YC-200 and YC-200 S plus are now commercially available in the United States. The